Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
Abstract Background The World Health Organization (WHO) recommends annual mass azithromycin distribution until districts drop below 5% prevalence of trachomatous inflammation—follicular (TF). Districts with very low TF prevalence may have little or no transmission of the ocular strains of Chlamydia...
Main Authors: | Abdou Amza, Boubacar Kadri, Beido Nassirou, Ahmed M. Arzika, Ariana Austin, Fanice Nyatigo, Elodie Lebas, Benjamin F. Arnold, Thomas M. Lietman, Catherine E. Oldenburg |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-020-01776-4 |
Similar Items
-
Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
by: Kevin Cyrus Hong, et al.
Published: (2009-07-01) -
Trachoma: from basics to clinic
by: Carvajal-Fernández, Julián, et al.
Published: (2017-07-01) -
TRACHOMA THERAPY: AN ALTERNATIVE REGIMEN
by: Muhammad Kamran Khalid, et al.
Published: (2014-01-01) -
The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial
by: Fengchen Liu, et al.
Published: (2014-03-01) -
Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study
by: Zelalem Tilahun, et al.
Published: (2018-08-01)